Drugs Health Pharma

Covid-19 virus leads to lung damage in UK patients after hospitalization

The Covid-19 virus, in some of the British patients discharged from hospitals, has led to lung damage which is irreversible and may get.

Read More
Drugs Pharma

Israeli researchers develop artificially intelligent pathological assistants

Israeli researchers have succeeded in making computers into pathological assistants at a time when healthcare companies are trying to overcome a global shortage.

Read More
Drugs Health Pharma

India’s drug regulator gives nod for world’s first nasal Covid-19 vaccine

India’s drug regulator, the Central Drugs Standard Control Organisation, has given its nod for the restricted use of the world’s first intra-nasal vaccine.

Read More
Drugs Pharma

Alembic Pharmaceuticals gets FDA nod for diclofenac

Alembic Pharmaceuticals, an Indian maker of generic drugs, has received FDA approval for diclofenac medicine used to treat osteoarthritis of the knees.

Read More
Drugs Health Medical Pharma

AstraZeneca to buy Neogene for $320 million

AstraZeneca, an Anglo-Swedish pharmaceutical company, is set to acquire Neogene Therapeutics, a biotechnology firm, for $320 million

Read More
Drugs Pharma

FDA probing Prolia as study reveals ‘serious outcomes’

The FDA is probing a drug, Prolia, used for the treatment of advanced kidney disease after initial investigations showed “a substantial risk with.

Read More
Drugs Health Medical Pharma

Baxter recalls hospital bed systems, FDA says ‘most serious’

Baxter International has pulled the plug on its hospital bed systems in a recall termed by the FDA as “most serious” as the.

Read More
Drugs Health Medical Pharma

Biovac signs deal for oral cholera vaccine with S.Korea’s IVI

Biovac, a South Africa-based biotechnology company, has signed a technology transfer agreement with a South Korean institute to make an oral cholera vaccine.

Read More
Drugs Pharma

Merck acquires Imago BioSciences for $1.35 billion

Merck, a US multinational pharmaceutical company, announced it would acquire Imago BioSciences for $1.35 billion.

Read More
Drugs Medical Pharma

Swedish researchers find possible biomarker for Covid-19

Swedish researchers have found a potential biomarker for severe Covid-19 disease that has claimed the lives of more than 6.5 million people globally.

Read More
X